TenderlineUK
Procurement Intelligence
Search
Find a TenderAwardedContract details notice
Published 21 May 2025, 13:15 BST

Official UK procurement notice

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

Official notice

Authority: NHS England (Central government)

Framework agreement2 lotsGoodsOpen procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)East Midlands (UKF)
+5 moreWest Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)
Framework ceiling (notional)£592,363,416envelope for 2 lots · framework ceiling, not attributable revenue · 1 value update
Submissions closed 26 Mar 2026awarded 1 Jun 2026
Award (standstill) to ACCORD-UK LTD +12 more2 awards
Framework period 2 yrsends 31 Aug 2028 · up to 31 Aug 2030 with extensions · starts 1 Sept 2026

What is being bought2 lots · detail below

Published requirement description

NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731

Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Open framework
Call-offs
every call-off is a further competition among the appointed suppliers
Bids received
26 bids on the busiest of 2 lots · 25 suppliers appointed
Framework period
2 yrs · up to 4 yrs from 1 Sept 2026
Who may buy through it

Please refer to Document No. 09 of the ITO Documents for the list of Participating Authorities/Pharmacy Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

Lots and requirements (2)Procurement structure

2 lots · all with a published value
Lot #1Tranche B for London & South of EnglandAwardedRenewal 2 yrsSMEPublished value£541,494,660

NHS Branded Medicines - Tranche B for London & South of England

Contract period: 1 Sept 2026 – 31 Aug 2028 (2 yrs) · up to 31 Aug 2030 with extensionsValue: £541,494,660 exc. VAT · £649,793,592 inc. VAT
Delivery: North East, North West, East Midlands, West Midlands, London, South East, South WestEligibility: SME eligible
Extensions: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. · With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
33600000 Pharmaceutical products
Lot #2Ustekinumab for North of England and Midlands & EastAwardedRenewal 1 yrSMEPublished value£50,868,757

NHS Branded Medicines - Ustekinumab for North of England and Midlands & East

Contract period: 1 Sept 2026 – 31 Aug 2027 (1 yr) · up to 31 Aug 2028 with extensionsValue: £50,868,757 exc. VAT · £61,042,508 inc. VAT
Delivery: North East, North West, East Midlands, West Midlands, London, South East, South WestEligibility: SME eligible
Extensions: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. · With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS Branded Medicines - Tranche B - London & South of England - 1…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use the vehicle
Please refer to Document No. 09 of the ITO Documents for the list of Participating Authorities/Pharmacy Purchasing Points
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
21 May 2025, 13:15 BST
Last source update
10 Jul 2026, 10:46 BST
Award evaluation window
Submission end – 29 May 2026
Authority reference
C414011
FTS notice number
2026/S 000-016135
Latest notice
Contract details notice (UK7)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)
Official registry OCID
ocds-h6vhtk-051a9d Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
26 Mar 2026, 13:00 GMT
Clarification deadline
19 Mar 2026, 17:00 GMT
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional info obtained from the abovementioned address. Tenders must be submitted to the abovementioned address

Timeline

21 May 2025 → 1 Sept 2026 · 11 dates
  1. Planning notice published
    21 May 2025, 13:15 BST
  2. Market engagement261 days ago
    27 Jan 2026, 23:59 GMT

    NHS England advises suppliers of an upcoming tender for the NHS Branded Medicines Agreement – Tranche B - Lot 1, scheduled to commence on 1 September 2026 for a 24-month term, with an option to extend for a further 24 months.

    Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

    The purpose of this notice is to inform existing and potential suppliers that, where deemed beneficial, a virtual 1:1 preliminary market meeting can be arranged. Please contact [email protected] to register your interest. A seven-day window for queries will be available via Atamis after all sessions have concluded.

    This framework will cover six therapy areas including adalimumab, bevacizumab, cytokine modulators, interleukin inhibitors, JAK inhibitors, and monoclonal antibodies.

  3. Tender notice published235 days ago
    23 Feb 2026, 14:41 GMT
  4. Next notice expected234 days ago
    23 Feb 2026, 23:59 GMT
  5. Clarification questions by211 days ago
    19 Mar 2026, 17:00 GMT
  6. Admission / appointment period ends204 days ago · period end, not a bid countdown
    26 Mar 2026, 13:00 GMT
  7. Award decision expected by139 days ago
    29 May 2026, 23:59 BST
  8. Assessment summaries sent129 days ago
    9 Jun 2026, 00:00 BST
  9. Standstill ends118 days ago
    19 Jun 2026, 23:59 BST
  10. Latest notice published98 days ago
    10 Jul 2026, 10:46 BST
  11. Contract starts45 days ago
    1 Sept 2026, 00:00 BST

Notice history

13 events · 7 releases on Find a Tender · since 21 May 2025
  1. Pipeline notice published
    21 May 2025, 13:15 BST
    UK1
  2. Pipeline notice published
    3 Jun 2025, 12:58 BST
    UK1
  3. Preliminary market engagement notice published
    14 Jan 2026, 09:56 GMT
    UK2
  4. Published value updated to £592,363,416
    14 Jan 2026, 09:56 GMT
    was £314,864,319
  5. Preliminary market engagement notice published
    18 Feb 2026, 12:08 GMT
    UK2
  6. Tender notice published
    23 Feb 2026, 14:41 GMT
    UK4
  7. Status changed to active
    23 Feb 2026, 14:41 GMT
  8. Procurement method changed
    23 Feb 2026, 14:41 GMT
  9. Deadline published: 26 Mar 2026, 13:00 GMT
    23 Feb 2026, 14:41 GMT
  10. Contract award notice published
    9 Jun 2026, 10:09 BST
    UK6
  11. Status changed to complete
    9 Jun 2026, 10:09 BST
  12. Contract signature expected
    24 Jun 2026, 23:59 BST
    scheduled
  13. Contract details notice published
    10 Jul 2026, 10:46 BST
    UK7
Published amendments (2)

Updated to Above Threshold Tender

Registration starts date updated

Routine re-releases (7)
  • 2026-02: 1 release · 18 Feb 2026
  • 2026-01: 1 release · 14 Jan 2026
  • 2025-06: 1 release · 3 Jun 2025
  • 2025-05: 1 release · 21 May 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 254 awards · see the list ↓
Bids received 265 from SMEs · busiest of 2 lots
Named bidders 26published on the award notice
Contracts signed 2latest 6 Jul 2026
Awarded toValueDateStatus
Lot 1 · Tranche B for London & South of England1 award
ACCORD-UK LTD, Biogen Idec Ltd, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare Uk Ltd, Galapagos Biotech LtdSME, Gedeon Richter UK Ltd +19 moreLot 1 - CM/PHR/25/5731/01 – NHS Branded Medicines Tranche B for London & South of England.1 Sept 2026 – 31 Aug 2028 · up to 31 Aug 2030Extensions: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. · Options: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.£813,863,5841 Jun 2026standstill to 19 Jun 2026Standstill
Lot 2 · Ustekinumab for North of England and Midlands & East1 award
Amgen Ltd, Biogen Idec Ltd, Celltrion Healthcare Uk Ltd, Fresenius Kabi Limited, Gedeon Richter UK Ltd, Janssen-Cilag Ltd +2 moreLot 2 -CM/PHR/25/5731/02 – NHS Branded Medicines for Ustekinumab for North of England and Midlands & East1 Sept 2026 – 31 Aug 2027 · up to 31 Aug 2028Extensions: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. · Options: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.£18,903,2121 Jun 2026standstill to 19 Jun 2026Standstill

Contracts

  • Lot 2 - CM/PHR/25/5731/02 - Ustekinumab NOFE & MAE

    Signed
    6 Jul 2026
    Value
    £18,903,212
    Period
    1 Sept 2026 – 31 Aug 2027 · up to 31 Aug 2028 with extensions
    Status
    active
    Extensions
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
    Options
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

  • Lot 1 - CM/PHR/25/5731/01 - NHS Branded Tranche B - London & SOFE

    Signed
    22 Jun 2026
    Value
    £813,863,584
    Period
    1 Sept 2026 – 31 Aug 2028 · up to 31 Aug 2030 with extensions
    Status
    active
    Extensions
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
    Options
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Tranche B for London & South of England26final-stage tenders50—
2 · Ustekinumab for North of England and Midlands & East8final-stage tenders10—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact name, email

Framework contractors & participating bidders

26 commercial parties on the notice · 25 awarded
  • ABBVIE LTDFramework contractorGB-PPON: PHRQ-1133-WGCH Weatherhead AbbVie House, Vanwall Road, Vanwall Business Park, Maidenhead, South East, SL6 4UBContact email
  • ACCORD-UK LTDFramework contractorGB-PPON: PBTN-3137-DHTG Whiddon Valley, Barnstaple, Devon, South West, EX32 8NSContact email
  • ALFASIGMA UK LIMITEDFramework contractorGB-PPON: PYDW-6316-ZVYQ Salisbury House, Station Road, Cambridge, East of England, CB1 2LAContact email
  • AMGEN LIMITEDFramework contractorGB-PPON: PDJG-8184-TCQQ 216 Cambridge Science Park, Milton Road, Cambridge, East of England, CB4 0WAContact email
  • AVENTIS PHARMA LIMITED t-a SanofiFramework contractorGB-PPON: PMBG-8218-QDPT 410 Thames Valley Park Drive, Reading, South East, RG6 1PTContact email
  • BIOGEN IDEC LIMITEDFramework contractorGB-PPON: PTGT-3385-PBMQ Building 5, Foundation Park, Roxborough Way, Maidenhead, South East, SL6 3UDContact email
  • BIOSIMILAR COLLABORATIONS IRELAND LIMITEDFramework contractorGB-PPON: PQQC-5869-LMVX Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin, IR, D13 R20R, IRContact email
  • CELLTRION HEALTHCARE UK LIMITEDFramework contractorGB-PPON: PYQL-4248-PXXY The Charter Building, Charter Place, Uxbridge, London, UB8 1JGContact email
  • DR REDDY'S LABORATORIES (UK) LIMITEDFramework contractorGB-PPON: PGGG-3877-XTJG 410 Cambridge Science Park, Milton Road, Cambridge, East of England, CB4 0PEContact email
  • FRESENIUS KABI LIMITEDFramework contractorGB-PPON: PZVH-4892-PJYY Cestrian Court, Eastgate Way, Manor Park, Runcorn, North West, WA7 1NTContact email
Show 16 more suppliers
  • GEDEON RICHTER (UK) LIMITEDFramework contractorGB-PPON: PVNN-9371-ZTBW 127 Shirland Rd, Maida Vale, London, London, W9 2EPContact email
  • GLAXOSMITHKLINE UK LIMITEDFramework contractorGB-PPON: PNVC-2547-YXMP 79 New Oxford Street, London, London, WC1A 1DGContact email
  • JANSSEN-CILAG LIMITEDFramework contractorGB-PPON: PTBW-9923-RLZD 50 -100 Holmers Farm Way, High Wycombe, South East, HP12 4EGContact email
  • MILPHARM LIMITEDFramework contractorGB-PPON: PCYZ-5538-QLGR 1 Roundwood Avenue , Stockley Park, Uxbridge, London, UB11 1AFContact email
  • ORGANON PHARMA (UK) LIMITEDFramework contractorGB-PPON: PTZC-8956-NPPT Shotton Lane, Cramlington, North East, NE23 3JUContact email
  • ORIFARM UK LTDFramework contractorGB-PPON: PQPW-1715-PJLT Ground Floor, Suite A2, Breakspear Park, Breakspear Way, Hemel Hempstead, East of England, HP2 4TZContact email
  • PFIZER LIMITEDFramework contractorGB-PPON: PCQW-3224-CMTG Ramsgate Road, Kent, South East, CT13 9NJContact email
  • ROCHE PRODUCTS LIMITEDFramework contractorGB-PPON: PXCG-4172-CHYM 6 Falcon Way, Shire Park, Welwyn Garden City, East of England, AL7 1TWContact email
  • SAMSUNG BIOEPIS UK LIMITEDFramework contractorGB-PPON: PNBG-7778-YPZQ 5th Floor, Profile West, 950 Great West Road,, Brentford, London, TW8 9ESContact email
  • SANDOZ LIMITEDFramework contractorGB-PPON: PNQL-1548-CYBZ Maxis 1 Western Road, Bracknell, South East, RG12 1RFContact email
  • SWEDISH ORPHAN BIOVITRUM LTDFramework contractorGB-PPON: PNNT-2898-LYZL Suite 2, Riverside 3, Granta Park, Great Abington, East of England, CB21 6ADContact email
  • TAKEDA UK LIMITEDBidder / tendererGB-PPON: PZNC-1575-PCQX 1 Kingdom Street, London, London, W2 6BD
  • TEVA UK LIMITEDFramework contractorGB-PPON: PWDD-6894-DXRM Ridings Point Whistler Drive, Glasshoughton, Castleford, Yorkshire & Humber, WF10 5HXContact email
  • THORNTON & ROSS LIMITEDFramework contractorGB-PPON: PWYH-6892-QYNN Linthwaite Labs, Manchester Road, Huddersfield, Yorkshire & Humber, HD7 5QHContact email
  • UCB PHARMA LIMITEDFramework contractorGB-PPON: PBPB-9589-WWBY 208 Bath Road, Slough, South East, SL1 3WEContact email
  • ZENTIVA PHARMA UK LIMITEDFramework contractorGB-PPON: PJTB-3347-PLGW 12 New Fetter Lane, London, London, EC4A 1JPContact email

Official documents & specifications (28)

Official links; attachments are not copied

Tender pack and attachments

Show 11 more documents

Notices published for this procedure